S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

SCPH scPharmaceuticals Inc

2.8801

-0.2399 (-7.69%)

08 Mar 2025 - Closed

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

scPharmaceuticals (NASDAQ:SCPH)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more scPharmaceuticals Charts.

scPharmaceuticals (NASDAQ:SCPH)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more scPharmaceuticals Charts.

scPharmaceuticals Inc News

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease
Friday 7 March 2025 (3 days ago) • GlobeNewswire Inc.

scPharmaceuticals Announces Participation in Two Upcoming Investor Conferences
Thursday 27 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 13 February 2025 (4 weeks ago) • Edgar (US Regulatory)

scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Thursday 6 February 2025 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Saturday 11 January 2025 (2 months ago) • Edgar (US Regulatory)

scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results
Saturday 11 January 2025 (2 months ago) • GlobeNewswire Inc.

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Tuesday 31 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 11 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (4 months ago) • Edgar (US Regulatory)

scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update
Thursday 14 November 2024 (4 months ago) • GlobeNewswire Inc.

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Thursday 29 August 2024 (6 months ago) • Edgar (US Regulatory)

More scPharmaceuticals Inc News Articles

BNP Paribas Issuance

Vontobel Financial Produ...

Intesa Sanpaolo

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions